questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins atténués
Vaccins atténués : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Vaccins atténués
Agents pathogènes
Immunisation
Tests sérologiques
Efficacité des vaccins
Immunité
Symptômes
2
Réactions aux vaccins
Effets secondaires
Fièvre
Maladies infectieuses
Réactions indésirables
Vaccins
Prévention
2
Préparation à la vaccination
Antécédents médicaux
Vaccins
Immunodépression
Sécurité des vaccins
Vaccins atténués
Traitements
2
Réactions allergiques
Traitement médical
Vaccins
Antécédents médicaux
Prévention
Vaccins
Complications
2
Complications
Infections
Vaccins atténués
Surveillance médicale
Effets indésirables
Vaccins
Facteurs de risque
2
Immunodépression
Grossesse
Vaccins atténués
Allergies
Évaluation médicale
Vaccins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins atténués : Questions médicales les plus fréquentes",
"headline": "Vaccins atténués : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins atténués : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-19",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins atténués"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vaccins atténués",
"alternateName": "Vaccines, Attenuated",
"code": {
"@type": "MedicalCode",
"code": "D014613",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Aitor Nogales",
"url": "https://questionsmedicales.fr/author/Aitor%20Nogales",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com."
}
},
{
"@type": "Person",
"name": "Charles Grose",
"url": "https://questionsmedicales.fr/author/Charles%20Grose",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA."
}
},
{
"@type": "Person",
"name": "Manish Patel",
"url": "https://questionsmedicales.fr/author/Manish%20Patel",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov."
}
},
{
"@type": "Person",
"name": "Jessie R Chung",
"url": "https://questionsmedicales.fr/author/Jessie%20R%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Clinically Selected Staphylococcus aureus",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37184389",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/aac.00328-23"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staphylococcus aureus adhesion to the host.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35705378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/nyas.14807"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staphylococcus aureus bacteremia in alcoholics.",
"datePublished": "2024-05-21",
"url": "https://questionsmedicales.fr/article/38771740",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0298612"
}
},
{
"@type": "ScholarlyArticle",
"name": "Update on Staphylococcus aureus bacteraemia.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/35942696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MCC.0000000000000974"
}
},
{
"@type": "ScholarlyArticle",
"name": "Phages for treatment of Staphylococcus aureus infection.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37739558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/bs.pmbts.2023.03.027"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins atténués",
"item": "https://questionsmedicales.fr/mesh/D014613"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins atténués - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins atténués",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins atténués",
"description": "Comment savoir si un vaccin est atténué ?\nQuels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Staphylococcus+aureus#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins atténués",
"description": "Quels symptômes peuvent apparaître après un vaccin atténué ?\nLes vaccins atténués causent-ils des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Staphylococcus+aureus#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins atténués",
"description": "Comment se préparer avant de recevoir un vaccin atténué ?\nLes vaccins atténués sont-ils sûrs pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Staphylococcus+aureus#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins atténués",
"description": "Que faire en cas de réaction sévère à un vaccin atténué ?\nLes vaccins atténués nécessitent-ils un traitement préventif ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Staphylococcus+aureus#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins atténués",
"description": "Quelles complications peuvent survenir avec un vaccin atténué ?\nLes complications des vaccins atténués sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Staphylococcus+aureus#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins atténués",
"description": "Qui devrait éviter les vaccins atténués ?\nLes antécédents d'allergies influencent-ils la vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Staphylococcus+aureus#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment savoir si un vaccin est atténué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents."
}
},
{
"@type": "Question",
"name": "Quels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après un vaccin atténué ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués causent-ils des maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée."
}
},
{
"@type": "Question",
"name": "Comment se préparer avant de recevoir un vaccin atténué ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués sont-ils sûrs pour tous ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées."
}
},
{
"@type": "Question",
"name": "Que faire en cas de réaction sévère à un vaccin atténué ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter immédiatement un professionnel de santé pour évaluer la situation."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués nécessitent-ils un traitement préventif ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, mais des antécédents médicaux doivent être évalués avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un vaccin atténué ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des infections chez les personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "Les complications des vaccins atténués sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance."
}
},
{
"@type": "Question",
"name": "Qui devrait éviter les vaccins atténués ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies influencent-ils la vaccination ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Vaccins atténués" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA. weger@vt.edu.
Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Tech, Blacksburg, VA, USA. weger@vt.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. piblanlo@gmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. luis_martinez@urmc.rochester.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochestergrid.16416.34, Rochester, New York, USA.
Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Texas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: lmartinez@txbiomed.org.
Publications dans "Vaccins atténués" :
Daptomycin is a last-resort antibiotic used for the treatment of infections caused by Gram-positive antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Treatment...
Staphylococcus aureus is a pathobiont capable of colonizing and infecting most tissues within the human body, resulting in a multitude of different clinical outcomes. Adhesion of S. aureus to the host...
Alcoholism associates with increased Staphylococcus aureus bacteremia incidence and mortality. The objective was to compare disease progression, treatment and prognosis of Staphylococcus aureus bacter...
The study design was a multicenter retrospective analysis of methicillin-sensitive Staphylococcus aureus bacteremia with 90-day follow-up. Patients were stratified as alcoholics or non-alcoholics base...
Alcoholics, versus non-alcoholics, were younger, typically male and more commonly had community-acquired Staphylococcus aureus bacteremia. No differences in McCabe´s classification of underlying condi...
Alcoholism deteriorates Staphylococcus aureus bacteremia prognosis, and our results suggests that this is predominantly through illness severity at bacteremia onset. Three quarters of Staphylococcus a...
To review recently published evidence relevant to Staphylococcus aureus bacteremia (SAB)....
Staphylococcus aureus is the most common pathogen causing co-infections and superinfections in patients with COVID-19. Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia ratios have sharply...
Our review confirms that Staphylococcus aureus represents a special aetiology among all causes of bloodstream infections. Pending results of platform and larger trials, its distinct epidemiology and d...
Combating multi-drug resistant bacterial infections should be a universal urgency. The gram- positive Staphylococcus aureus (S. aureus) bacteria are generally harmless; healthy people frequently have ...
Staphylococcus aureus is a common clinical pathogen. Does every S. aureus infection require anti-MRSA drugs? Reported here are three cases of a community-acquired infection with S. aureus. The first c...
Staphylococcus aureus bacteremia patients characteristics at a tertiary hospital are described, and complications, mortality and associated factors are analyzed....
Data from patients with S. aureus bacteremia admitted between March 2020 and February2021 at Miguel Servet university hospital in Zaragoza were retrospectively analyzed....
Results showed a 14 days mortality of 24.2% and an 30 days mortality of 40%. Overall survival decreased with complications appearance [HR 3.1 (1.2-8.05)] and age over 65 years [HR 3.1 (1.4-6.6)]. The ...
High 14- and 30-days mortality were found, as well as a worse evolution in older age patients, with sepsis presence, and with greater number of positive blood cultures and times to positive blood cult...
Pseudomonas aeruginosa inhibits or eradicates Staphylococcus aureus in most in vitro settings. Nonetheless, P. aeruginosa and S. aureus are commonly isolated from chronically infected, nonhealing woun...
The spread of antibiotic resistance is attracting increased attention to combination-based treatments. Although drug combinations have been studied extensively for their effects on bacterial growth...
Staphylococcus aureus is an uncommon cause of community-acquired bacterial meningitis. We aimed to describe patients with this disease....
We evaluated clinical characteristics and outcome of adults with community-acquired S. aureus meningitis from prospective nationwide cohort studies from Denmark (2015-2020) and the Netherlands (2006-2...
We evaluated 111 episodes of community-acquired S. aureus meningitis: 65 from Denmark and 46 from the Netherlands. The median age was 66 years (interquartile range [IQR] 50-74) and 43 of 111 patients ...
Community-acquired S. aureus meningitis is a severe disease with a high case fatality rate, occurring mainly in patients with concomitant endocarditis or spondylodiscitis....